Month: January 2024

Consolidated GEO Production per Quarter and LTM000’s GEO, current and constant prices as reportedROAD TOWN, British Virgin Islands, Jan. 10, 2024 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce Q4 2023 preliminary production results from the Company’s four operating mines: Aranzazu Mine, EPP Mines (Apoena Operation), San Andres Mine (Minosa Operation), and Almas Mine. Total production in Q4 2023 reached 69,194 gold equivalent ounces (“GEO”)1, a 7% increase compared to Q3 2023 as a result of improved operating performance at three mines, Apoena (EPP), Minosa (San Andrés) and Almas. When compared to the same period last year, production increased by 2% mainly due to Almas achieving commercial production in August 2023. Total production for 2023...

SAN JOSE, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) (the “Company” or “Infinera”) today reaffirmed certain preliminary unaudited financial result ranges for the third quarter and outlook ranges for the fourth quarter of 2023. Due to the preliminary nature of the announcement, and since the Company is still finalizing its financials, only select financial metrics are being referenced at this time. The Company now believesIts preliminary revenue and preliminary net income per diluted share for the third quarter of 2023 will be within or exceed the ranges provided on November 8, 2023. Its preliminary revenue and preliminary net income per diluted share for the fourth quarter of 2023 will be within or exceed the outlook ranges provided on November 8, 2023, supported by strong bookings in the quarter.Infinera...

— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 10, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that the New Drug Application (“NDA”) for sovleplenib for the treatment of adult patients with primary immune thrombocytopenia (“ITP”) has been accepted for review and granted priority review by the China National Medical Products Administration (“NMPA”). Sovleplenib is a novel, selective, oral inhibitor targeting spleen tyrosine kinase (“Syk”), being developed for the treatment of hematological...

The drill trail allows for drive-in-access for trucks, drilling rigs, and wireline equipment to begin drilling at core well two at the Robinsons River Salt Project VANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) (“Vortex” or the “Company”) is pleased to announce the commencement of the clearing process for approximately 3.1 km of drill trail road in preparation for the drilling of the second core well at the Robinsons River Salt Project (the “Project”). The work is being completed by On Grade Construction of Stephenville, Newfoundland and Labrador, a subcontractor hired under the supervision and project management of the Company’s primary consulting partner, RESPEC Consulting Inc (“RESPEC”). The priority from RESPEC has been to assist the mobilizing efforts with...

HOUSTON, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) — Today, Global System Dynamics, Inc. (“GSD,” the “Company”) announced that it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with the Nasdaq’s annual shareholder meeting requirement, pursuant to Nasdaq Listing Rule 5620(a). On January 5, 2024, Nasdaq notified the Company in a letter (the “Notice Letter”) that it did not comply with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual shareholder’s meeting no later than one year following its last fiscal year. To date, the Company has not held its annual shareholder’s meeting. The Notice Letter stated that such deficiency would be an additional factor considered by the Nasdaq Hearing Panel (the “Panel”) in the Company’s hearing regarding delisting from the Nasdaq....

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Middlefield Limited (the “Manager”), the manager of International Clean Power Dividend Fund (“CLP”), is pleased to announce that CLP intends to merge (the “Merger”) into Infrastructure Dividend Split Corp. (“Infrastructure Split Corp.”), a split share corporation to be formed in connection with the Merger, with unitholders of CLP becoming Class A shareholders of Infrastructure Split Corp. In conjunction with the Merger, Infrastructure Split Corp. plans to undertake an offering of a number of preferred shares (the “Preferred Shares”) approximately equal to the number of Class A shares that are outstanding immediately following the Merger. Terms of the Preferred Shares will be announced at least 60 days prior to the Preferred Share offering and will be included in an information circular...

– ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p

AS PRFoods resolutions adopted by the Extraordinary General Meeting of Shareholders of AS PRFoods on 10.01.2024 The extraordinary general meeting of shareholders (the General Meeting) of AS PRFoods (the Company) was held at 9.00 am on Wednesday 10.01.2024 at Peetri 12 (Kai Art Center), 10415 Tallinn. The notice of the General Meeting together with the agenda was published on 20 December 2023 via the Nasdaq Tallinn Stock Exchange information system and on the website of the Company at https://prfoods.ee/prfoods. The notice of the General Meeting was also published in Eesti Päevaleht of 20 December 2023. 6 shareholders registered for the General Meeting, whose shares represented 26 004 203 votes, which constitute 67,22% of all the votes represented by the share capital of the Company, and thus the General Meeting had the necessary quorum...

AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 on an as-reported basis. Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent over the prior year on an as-reported basis.   “2023 was a monumental year for Globus Medical. We completed our merger with NuVasive to create the most innovative technology company in the spine market. Our integration is proceeding according to plan and we are pleased with our sales retention thus far. To cap off this eventful year,...